Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Translational Research : the Journal of Laboratory and Clinical Medicine|February 14, 2021
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studiesCarlota Dobaño, Rebeca Santano, Alfons Jiménez, et al.
Science (New York, N.Y.)|June 4, 2016
ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodelingRoni H G Wright, Antonios Lioutas, Francois Le Dily, et al.
Journal of Clinical Microbiology|October 31, 2020
Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 AntigensCarlota Dobaño, Marta Vidal, Rebeca Santano, et al.
Microbiome|December 8, 2018
Citizen science charts two major "stomatotypes" in the oral microbiome of adolescents and reveals links with habits and drinking water compositionJesse R Willis, Pedro González-Torres, Alexandros A Pittis, et al.
Immunology|September 6, 2022
Eleven-month longitudinal study of antibodies in SARS-CoV-2 exposed and naïve primary health care workers upon COVID-19 vaccinationCarlota Dobaño, Anna Ramírez-Morros, Selena Alonso, et al.
Nature Communications|May 13, 2022
Genome editing in animals with minimal PAM CRISPR-Cas9 enzymesJeremy Vicencio, Carlos Sánchez-Bolaños, Ismael Moreno-Sánchez, et al.
BMC Medicine|October 12, 2022
Sustained seropositivity up to 20.5 months after COVID-19Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, et al.
BMC Medicine|September 15, 2022
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in CataloniaMarianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
Nature Communications|February 5, 2024
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activityLeire de Campos-Mata, Benjamin Trinité, Andrea Modrego, et al.
Ebiomedicine|January 15, 2022
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workersGemma Moncunill, Ruth Aguilar, Marta Ribes, et al.
Pageof 4